End-of-day quote
Korea S.E.
06:00:00 2024-04-29 pm EDT
5-day change
1st Jan Change
19,630
KRW
-1.85%
+4.64%
-31.36%
I-SENS, Inc.’s Equity Buyback announced on August 20, 2018 has expired with 141,237 shares, representing 1.03% for KRW 2,968.78 million.
The Company expired its plan on February 19, 2019.
I-SENS, Inc. announced that it has received KRW 50 billion in funding from NH Investment & Securities Co., Ltd., Atinum Investment Co., Ltd
Apr. 29
CI
I-SENS, Inc. announced that it expects to receive KRW 50 billion in funding from NH Investment & Securities Co., Ltd., Atinum Investment Co., Ltd
Apr. 25
CI
I-SENS, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Mar. 20
CI
I-SENS, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Nov. 14
CI
I-SENS, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
23-08-11
CI
I-SENS, Inc. completed the acquisition of AgaMatrix, Inc.
23-06-22
CI
I-SENS, Inc. agreed to acquire AgaMatrix, Inc. for $20 million.
23-05-15
CI
I-SENS, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-14
CI
I-SENS, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
23-03-22
CI
I-SENS, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
22-11-14
CI
I-SENS, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
22-08-15
CI
I-SENS, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
22-05-12
CI
I-SENS, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
22-03-17
CI
I-SENS, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
21-11-12
CI
Tranche Update on i-SENS, Inc.'s Equity Buyback Plan announced on August 20, 2018.
19-02-19
CI
Tranche Update on i-SENS, Inc.'s Equity Buyback Plan announced on August 20, 2018.
19-02-19
CI
Tranche Update on i-SENS, Inc.'s Equity Buyback Plan announced on August 20, 2018.
19-02-19
CI
I-SENS, Inc.’s Equity Buyback announced on August 20, 2018 has expired with 141,237 shares, representing 1.03% for KRW 2,968.78 million.
19-02-18
CI
I-SENS, Inc. announces an Equity Buyback for KRW 3,000 million worth of its shares.
18-08-19
CI
I-SENS, Inc. authorizes a Buyback Plan.
18-08-19
CI
Arkray, Inc. acquired 0.19% stake in i-SENS, Inc. from Geun Sig Cha for approximately KRW 830 million.
15-12-06
CI
Wasatch Advisors Inc. and one related party acquired 5.03% stake in i-SENS, Inc..
14-03-28
CI
National Pension Service acquired 5.06% stake in i-SENS, Inc..
14-01-08
CI
Truston Asset Management Co., Ltd. acquired 5.3% stake in i-SENS, Inc..
13-11-03
CI
I-SENS, Inc. has completed an IPO in the amount of KRW 17.10 billion.
13-01-28
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
i-SENS, Inc. is a Korea-based company mainly engaged in the manufacture and sale of biosensors. The Companyâs products consist of blood glucose monitoring systems, including blood glucose monitors, blood glucose meters, glucose monitors, blood glucose meter kits and blood sugar meters under the brand names of CareSens, MedTrust, BGStar, Barozen and others; electrolyte analyzers and cartridges; immunosensors, as well as other related accessories, such as connectors, lancets, blood glucose data management software and lancing devices, among others. The Company distributes its products within domestic market and to overseas markets including Japan, Europe, the United States and others.
More about the company
Last Close Price
19,630
KRW
Average target price
31,750
KRW
Spread / Average Target
+61.74%
Consensus
1st Jan change
Capi.
-31.36% 390M +73.09% 12.37B -18.39% 7.96B +14.33% 7.09B +4.77% 5.83B +11.77% 5.35B +29.65% 4.63B -17.29% 4B -35.92% 2.41B +1.24% 2B
Medical Equipment
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1